APA-Zitierstil (7. Ausg.)

Sanchorawala, V., & Schönland, S. (2017). A phase 1/2 study of the oral proteasome inhibitor ixazomib in relapsed or refractory AL amyloidosis. Blood, 130(5), . https://doi.org/10.1182/blood-2017-03-771220

Chicago-Zitierstil (17. Ausg.)

Sanchorawala, Vaishali, und Stefan Schönland. "A Phase 1/2 Study of the Oral Proteasome Inhibitor Ixazomib in Relapsed or Refractory AL Amyloidosis." Blood 130, no. 5 (2017). https://doi.org/10.1182/blood-2017-03-771220.

MLA-Zitierstil (9. Ausg.)

Sanchorawala, Vaishali, und Stefan Schönland. "A Phase 1/2 Study of the Oral Proteasome Inhibitor Ixazomib in Relapsed or Refractory AL Amyloidosis." Blood, vol. 130, no. 5, 2017, https://doi.org/10.1182/blood-2017-03-771220.